論文・総説 - 吉田　雅幸

41. Yoshida Hiroshi, Tada Hayato, Ito Kumie, Kishimoto Yoshimi, Yanai Hidekatsu, Okamura Tomonori, Ikewaki Katsunori, Inagaki Kyoko, Shoji Tetsuo, Bujo Hideaki, Miida Takashi, Yoshida Masayuki, Kuzuya Masafumi, Yamashita Shizuya. 健康な日本人における血清非コレステロールステロールの男女別基準値(Reference Intervals of Serum Non-Cholesterol Sterols by Gender in Healthy Japanese Individuals) Journal of Atherosclerosis and Thrombosis. 2020.05; 27 (5): 409-417. ( 医中誌 )

42. Higashijima Y, Matsui Y, Shimamura T, Nakaki R, Nagai N, Tsutsumi S, Abe Y, Link VM, Osaka M, Yoshida M, Watanabe R, Tanaka T, Taguchi A, Miura M, Ruan X, Li G, Inoue T, Nangaku M, Kimura H, Furukawa T, Aburatani H, Wada Y, Ruan Y, Glass CK, Kanki Y. Coordinated demethylation of H3K9 and H3K27 is required for rapid inflammatory responses of endothelial cells. The EMBO journal. 2020.04; 39 (7): e103949. ( PubMed, DOI )

43. Fukaishi T, Minami I, Masuda S, Miyachi Y, Tsujimoto K, Izumiyama H, Hashimoto K, Yoshida M, Takahashi S, Kashimada K, Morio T, Kosaki K, Maezawa Y, Yokote K, Yoshimoto T, Yamada T. A case of generalized lipodystrophy-associated progeroid syndrome treated by leptin replacement with short and long-term monitoring of the metabolic and endocrine profiles. Endocrine journal. 2020.02; 67 (2): 211-218. ( PubMed, DOI )

44. Fukaishi Takahiro, Minami Isao, Masuda Seizaburo, Miyachi Yasutaka, Tsujimoto Kazutaka, Izumiyama Hajime, Hashimoto Koshi, Yoshida Masayuki, Takahashi Sayako, Kashimada Kenichi, Morio Tomohiro, Kosaki Kenjiro, Maezawa Yoshiro, Yokote Koutaro, Yoshimoto Takanobu, Yamada Tetsuya. レプチン補充療法および代謝・内分泌プロファイルの短期・長期モニタリングを施行された全身性脂肪萎縮症関連早老症の1例(A case of generalized lipodystrophy-associated progeroid syndrome treated by leptin replacement with short and long-term monitoring of the metabolic and endocrine profiles) Endocrine Journal. 2020.02; 67 (2): 211-218. ( 医中誌 )

45. Doshida Y, Sano H, Iwabuchi S, Aigaki T, Yoshida M, Hashimoto S, Ishigami A. Age-associated changes in the transcriptomes of non-cultured adipose-derived stem cells from young and old mice assessed via single-cell transcriptome analysis. PloS one. 2020; 15 (11): e0242171. ( PubMed, DOI )

46. Nishi H., Inoue R., Osaka M., Inoue T., Yoshida M., Nangaku M.. Neutrophil interferon-induced, double-stranded RNA-activated protein kinase (EIF2AK2) mediates vascular adhesion and transmigration in non-viral inflammatory disease EUROPEAN JOURNAL OF IMMUNOLOGY. 2019.10; 49 582.

47. Yoshida H, Tada H, Ito K, Kishimoto Y, Yanai H, Okamura T, Ikewaki K, Inagaki K, Shoji T, Bujo H, Miida T, Yoshida M, Kuzuya M, Yamashita S. Reference Intervals of Serum Non-Cholesterol Sterols by Gender in Healthy Japanese Individuals. Journal of atherosclerosis and thrombosis. 2019.09; ( PubMed, DOI )

48. Takahashi Kenta, Oshima Noriko, Nakamura Reiko, Iwahara Yuki, Wakana Kimio, Yoshida Masayuki, Miyasaka Naoyuki. Detection of hereditary gynecologic cancer by screening and risk assessment using questionnaires in gynecological outpatient clinic(和訳中) The Journal of Obstetrics and Gynaecology Research. 2019.08; 45 (8): 1682. ( 医中誌 )

49. Dewan Syed Masudur Rahman, Shiraishi Orie, Deushi Michiyo, Tani Mariko, Osaka Mizuko, Yoshida Masayuki. C5aによる好中球β2インテグリン活性化はPKCδの膜移行に関与する(C5a-induced β2 integrin activation in neutrophils involves membrane translocation of PKC δ) 日本動脈硬化学会総会プログラム・抄録集. 2019.07; 51回 2-P. ( 医中誌 )

50. Hirayama Atsushi, Yamashita Shizuya, Ruzza Andrea, Inomata Hyoe, Cyrille Marcoli, Lu Chen, Hamer Andrew W., Yoshida Masayuki, Kiyosue Arihiro, Teramoto Tamio. Long-Term Treatment With Evolocumab Among Japanese Patients - Final Report of the OSLER Open-Label Extension Studies CIRCULATION JOURNAL. 2019.05; 83 (5): 971-977. ( PubMed, DOI )

51. Nohara Atsushi, Otsubo Yoshihiko, Yanagi Koji, Yoshida Masayuki, Ikewaki Katsunori, Harada-Shiba Mariko, Jurecka Agnieszka. ホモ接合型家族性高コレステロール血症(HoFH)の日本人患者におけるロミタピドの安全性と有効性　AEGR-733-301長期延長試験の結果(Safety and Efficacy of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia(HoFH): Results from the AEGR-733-301 Long-Term Extension Study) Journal of Atherosclerosis and Thrombosis. 2019.04; 26 (4): 368-377. ( 医中誌 )

52. Hirayama Atsushi, Yamashita Shizuya, Ruzza Andrea, Inomata Hyoe, Cyrille Marcoli, Hamer Andrew W., Yoshida Masayuki, Kiyosue Arihiro, Teramoto Tamio. 日本人患者におけるエボロクマブによる長期治療　OSLER非盲検延長試験の最終報告(Long-Term Treatment With Evolocumab Among Japanese Patients: Final Report of the OSLER Open-Label Extension Studies) Circulation Journal. 2019.04; 83 (5): 971-977. ( 医中誌 )

53. Hirayama Atsushi, Yamashita Shizuya, Ruzza Andrea, Inomata Hyoe, Cyrille Marcoli, Hamer Andrew, Yoshida Masayuki, Kiyosue Arihiro, Teramoto Tamio. 日本人患者集団におけるevolocumabのOSLER非盲検延長試験の5年間の最終報告(Final 5-Year Report of the OSLER Open-Label Extension Studies of Evolocumab in the Japanese Patient Population) 日本循環器学会学術集会抄録集. 2019.03; 83回 LBCT2-4. ( 医中誌 )

54. Takahashi Kenta, Oshima Noriko, Nakamura Reiko, Iwahara Yuki, Wakana Kimio, Yoshida Masayuki, Miyasaka Naoyuki. 婦人科外来部門における問診票スクリーニングを用いた遺伝性腫瘍の検出(Detection of hereditary gynecologic cancer by screening and risk assessment using questionnaires in gynecological outpatient clinic) 日本産科婦人科学会雑誌. 2019.02; 71 (臨増): S-196. ( 医中誌 )

55. Kameyama Noriko, Maruyama Chizuko, Kitagawa Fuyuha, Nishii Kazunobu, Uenomachi Kaori, Katayama Yayoi, Koga Hiromi, Chikamoto Naoko, Kuwata Yuko, Torigoe Junko, Arimoto Masako, Tokumaru Toshiaki, Ikewaki Katsunori, Nohara Atsushi, Otsubo Yoshihiko, Yanagi Koji, Yoshida Masayuki, Harada-Shiba Mariko. ホモ接合型家族性高コレステロール血症の日本人患者におけるロミタピド治療に対する56週間の低脂肪食摂取(Dietary Intake during 56 Weeks of a Low-Fat Diet for Lomitapide Treatment in Japanese Patients with Homozygous Familial Hypercholesterolemia) Journal of Atherosclerosis and Thrombosis. 2019.01; 26 (1): 72-83. ( 医中誌 )

56. Kameyama Noriko, Maruyama Chizuko, Kitagawa Fuyuha, Nishii Kazunobu, Uenomachi Kaori, Katayama Yayoi, Koga Hiromi, Chikamoto Naoko, Kuwata Yuko, Torigoe Junko, Arimoto Masako, Tokumaru Toshiaki, Ikewaki Katsunori, Nohara Atsushi, Otsubo Yoshihiko, Yanagi Koji, Yoshida Masayuki, Harada-Shiba Mariko. Dietary Intake during 56 Weeks of a Low-Fat Diet for Lomitapide Treatment in Japanese Patients with Homozygous Familial Hypercholesterolemia JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS. 2019; 26 (1): 72-83. ( PubMed, DOI )

57. Nohara Atsushi, Otsubo Yoshihiko, Yanagi Koji, Yoshida Masayuki, Ikewaki Katsunori, Harada-Shiba Mariko, Jurecka Agnieszka. Safety and Efficacy of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia (HoFH): Results from the AEGR-733-301 Long-Term Extension Study JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS. 2019; 26 (4): 368-377. ( PubMed, DOI )

58. Kamijo Y, Ishii H, Yamamoto T, Kobayashi K, Asano H, Miake S, Kanda E, Urata H, Yoshida M. Potential Impact on Lipoprotein Subfractions in Type 2 Diabetes. Clinical medicine insights. Endocrinology and diabetes. 2019; 12 1179551419866811. ( PubMed, DOI )

59. Kawashima Saki, Funakoshi Tomoko, Sato Yasunori, Saito Norikatsu, Ohsawa Hajime, Kurita Katsumi, Nagata Kisaburo, Yoshida Masayuki, Ishigami Akihito. Protective effect of pre- and post-vitamin C treatments on UVB-irradiation-induced skin damage SCIENTIFIC REPORTS. 2018.11; 8 (1): 16199. ( PubMed, DOI )

60. Bloss Jeffrey D., Nohara Atsushi, Otsubo Yoshihiko, Yanagi Koji, Yoshida Masayuki, Ikewaki Katsunori, Harada-Shiba Mariko, Jurecka Agnieszka. ホモ接合性家族性高コレステロール血症(HoFH)の日本人患者におけるlomitapideの安全性と有効性(Safety and efficacy of lomitapide in Japanese patients with Homozygous Familial Hypercholesterolemia(HoFH)) 日本心臓病学会学術集会抄録. 2018.09; 66回 P-026. ( 医中誌 )